共 50 条
- [31] RITUXIMAB PLUS SARGRAMOSTIM FOR THE TREATMENT OF NEWLY DIAGNOSED FOLLICULAR LYMPHOMA: FINAL RESULTS OF A PHASE II STUDYANNALS OF ONCOLOGY, 2011, 22 : 187 - 187Fowler, N.Mclaughlin, P.Fisch, M.Dakhil, S.Bury, M.Fayad, L.Shah, J.Neelapu, S.Romaguera, J.Rodriguez, D.Ayala, A.Kwak, L.
- [32] The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (VCR) in Treating Mantle Cell LymphomaBLOOD, 2023, 142Pu, Jeffrey J.Berger, KristinZheng, ChunleiDo, Nhan V.Claxton, David F.Ehmann, W. ChristopherDrabick, Joseph J.Thomas, Loughran P., Jr.Epner, Elliot
- [33] Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphomaEUROPEAN JOURNAL OF CANCER, 2002, 38 (13) : 1739 - 1746Rummel, MJChow, KUKarakas, TJäager, EMezger, Jvon Grünhagen, USchalk, KPBurkhard, OHansmann, MLRitzel, HBergmann, LHoelzer, DMitrou, PSS
- [34] Acalabrutinib and Rituximab in Elderly Patients with Newly Diagnosed Mantle Cell Lymphoma Including a Matched Population-Based External Comparator- the Nordic Lymphoma Group NLG-MCL8 (ALTAMIRA) Phase II TrialBLOOD, 2024, 144 : 747 - 748Jerkeman, MatsWader, Karin FahlGlimelius, IngridPasanen, AnnikaKim, Won SeogHansen, Louise KrugerRiise, JonHutchings, MartinElhussein, Hashim HusseinNiemann, Carsten UtoftJorgensen, Rasmus Rask KraghEl-Galaly, Tarec ChristofferEhinger, MatsBeiske, KlausAmini, Rose-MarieMoller, Michael BoeKarjalainen-Lindsberg, Marja-LiisaChristensen, Jacob Haaber
- [35] A phase I/II study of lenalidomide (Len) in combination with rituximab (R) in relapsed/refractory mantle cell lymphoma (MCL) with early evidence of efficacyJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Wang, M.Fayad, L.Hagemeister, F.Neelapu, S.Bell, N.Byrne, C.Knight, R.Zeldis, J.Kwak, L.Romaguera, J.
- [36] Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphomaJOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 546 - 553Foran, JMRohatiner, AZSCoiffier, BBarbui, TJohnson, SAHiddemann, WRadford, JANorton, AJTollerfield, SMWilson, MPLister, TA
- [37] Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphomaBLOOD, 2012, 119 (18) : 4123 - 4128Younes, AnasOki, YasuhiroMcLaughlin, PeterCopeland, Amanda R.Goy, AndrePro, BarbaraFeng, LeiYuan, YingChuang, Hubert H.Macapinlac, Homer A.Hagemeister, FredrickRomaguera, JorgeSamaniego, FelipeFanale, Michelle A.Dabaja, Bouthaina ShbibRodriguez, Maria A.Dang, NamKwak, Larry W.Neelapu, Sattva S.Fayad, Luis E.
- [38] European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphomaJOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 317 - 324Foran, JMRohatiner, AZSCunningham, DPopescu, RASolal-Celigny, PGhielmini, MCoiffier, BJohnson, PWMGisselbrecht, CReyes, FRadford, JABessell, EMSouleau, BBenzohra, ALister, TA
- [39] Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 748 - 755Obr, AlesProchazka, VitPapajik, TomasKlener, Pavel, Jr.Janikova, AndreaSalek, DavidBelada, DavidPytlik, RobertSykorova, AliceMocikova, HeidiSimkovic, MartinCampr, VitDlouha, JitkaFurst, TomasTrneny, Marek
- [40] Combination of Ibrutinib with Rituximab (IR) in Previously Untreated Older Patients with Mantle Cell Lymphoma (MCL) - a Phase II Clinical TrialBLOOD, 2020, 136Jain, PreeteshYao, YixinZhao, ShuangtaoLiu, YangHill, HollyChe, YuxuanLi, YijingJordan, Alexa A.McIntosh, JosephLee, Hun JuSteiner, Raphael EricSamaniego, FelipeWestin, JasonNastoupil, Loretta J.Nair, RanjitAhmed, SairahOk, Chi YoungKanagal-Shamanna, RashmiOriabure, OnyekaXu, GuofangChen, WendyMoghrabi, OmarMcClain, Chloe MarieBadillo, MariaThirumurthi, SelviSantos, DavidIliescu, CezarYin, C. CameronLi, ShaoyingTang, GuilinVega, FranciscoNeelapu, Sattva S.Flowers, ChristopherWang, LinghuaWang, Michael